Skip to content

2010 Press Releases

Dec 3, 2010

FDA Advisory Committee Recommends Approval to Expand Use of LAP-BAND® Adjustable Gastric Banding System for Obese Adults  

Nov 25, 2010

New treatment targets natural tears for dry eyes  

Nov 17, 2010

Discover the Power of the Lash  

Nov 1, 2010

Allergan Reports Third Quarter 2010 Operating Results  

Oct 15, 2010

ADDING MULTIMEDIA BOTOX(R) (onabotulinumtoxinA) FDA Approved as Prophylactic Treatment Option for Adult Chronic Migraine Sufferers  

Oct 15, 2010

BOTOX(R) (onabotulinumtoxinA) FDA Approved as Prophylactic Treatment Option for Adult Chronic Migraine Sufferers  

Oct 4, 2010

Allergan Announces Quarterly Conference Call  

Sep 24, 2010

Allergan Receives FDA Approval for OZURDEX(R) as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye  

Sep 1, 2010

Allergan Resolves United States Government Investigation of Past Sales and Marketing Practices Relating to Certain Therapeutic Uses of BOTOX(R)  

Aug 31, 2010

Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients  

Aug 2, 2010

Allergan Reports Second Quarter 2010 Operating Results  

Jul 9, 2010

BOTOX(R) Receives First Authorisation in UK as Preventative Treatment in Chronic Migraine  

Jul 2, 2010

Allergan Announces Quarterly Conference Call  

Jun 15, 2010

Lifestyle Designer Kathy Ireland, Professional Ballroom Dancer Chelsie Hightower and Style Guide Bobbie Thomas Lead the LATISSE(R) Wishes Challenge Campaign to Benefit the Make-A-Wish Foundation(R)  

Jun 7, 2010

Allergan Receives CEO Cancer Gold Standard(TM) Accreditation  

May 19, 2010

Allergan Receives FDA Approval for ZYMAXID(TM) Ophthalmic Solution  

May 13, 2010

Allergan, Inc. Launches Public Awareness and Advocacy Campaign to Urge Greater Attention to Critical Need for Both Prevention and Treatment to Effectively Address Adult Obesity  

Apr 30, 2010

Allergan Reports First Quarter 2010 Operating Results  

Apr 2, 2010

Allergan Announces Quarterly Conference Call  

Apr 1, 2010

Allergan and Serenity Pharmaceuticals Enter into Global Agreement for the Treatment of Nocturia  

Showing 1-20 of 28
Page: 1 2
 Next 20